Limba
|
Cilofexor(GS-9674) is a potent, selective oral agonist of farnesoid X receptor (FXR)with an EC50 of 43 nM. It has demonstrated anti-inflammatory, antifibrotic effects, and reduced portal pressure in preclinical liver fibrosis models, showing potential therapeutic benefit for primary sclerosing cholangitis (PSC) and nonalcoholic steatohepatitis (NASH) research.
Price | 2.884,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Cilofexor(GS-9674) is a potent, selective oral agonist of farnesoid X receptor (FXR)with an EC50 of 43 nM. It has demonstrated anti-inflammatory, antifibrotic effects, and reduced portal pressure in preclinical liver fibrosis models, showing potential therapeutic benefit for primary sclerosing cholangitis (PSC) and nonalcoholic steatohepatitis (NASH) research. |